Cepheid
Jack Sawyer is a highly experienced professional in market access strategy and health economics, currently serving as the Director of Market Access Strategy at Cepheid since May 2021. Previously, Jack held various senior management roles at Philips, including Senior Manager for Acute Care Portfolio Marketing and Health Economics and Market Access. Prior experience includes a position as Associate Principal at Charles River Associates and multiple roles at Boston Healthcare Associates. Jack's early career involved an internship at the Centers for Medicare & Medicaid Services and Human Rights Watch. Jack holds a Master of Public Health from Harvard University, a Juris Doctor from Case Western Reserve University, and a Bachelor's Degree in Neuroscience from Franklin & Marshall College.
This person is not in any offices
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.